X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (28) 28
index medicus (26) 26
hematology (25) 25
male (21) 21
female (19) 19
middle aged (19) 19
adult (17) 17
chemotherapy (11) 11
life sciences (10) 10
lymphomas (10) 10
treatment outcome (10) 10
adolescent (9) 9
aged (9) 9
oncology (9) 9
cancer (8) 8
lymphoma (8) 8
transplantation (8) 8
care and treatment (7) 7
recurrence (7) 7
retrospective studies (7) 7
antineoplastic combined chemotherapy protocols - therapeutic use (6) 6
follow-up studies (6) 6
hodgkin disease - pathology (6) 6
hodgkin lymphoma (6) 6
stem cells (6) 6
biopsy (5) 5
disease (5) 5
hematopoietic stem cell transplantation - methods (5) 5
hodgkin disease - mortality (5) 5
neoplasm staging (5) 5
phase-ii (5) 5
risk factors (5) 5
stem cell transplantation (5) 5
young adult (5) 5
doxorubicin - therapeutic use (4) 4
high-dose chemotherapy (4) 4
hodgkin disease - drug therapy (4) 4
hodgkin's disease (4) 4
immunology (4) 4
mutation (4) 4
online only (4) 4
online only articles (4) 4
patients (4) 4
positron-emission-tomography (4) 4
prognostic-factors (4) 4
rituximab (4) 4
stem-cell transplantation (4) 4
survival analysis (4) 4
[sdv.can]life sciences [q-bio]/cancer (3) 3
[sdv]life sciences [q-bio] (3) 3
abridged index medicus (3) 3
aged, 80 and over (3) 3
antineoplastic combined chemotherapy protocols - administration & dosage (3) 3
b cells (3) 3
b-cell lymphoma (3) 3
brentuximab vedotin (3) 3
child (3) 3
diseases (3) 3
hemic and lymphatic diseases (3) 3
hodgkin disease - diagnosis (3) 3
hodgkin disease - metabolism (3) 3
hodgkin disease - therapy (3) 3
human health and pathology (3) 3
immunodeficiency (3) 3
lymphadenopathy (3) 3
medical research (3) 3
medicine, experimental (3) 3
phenotype (3) 3
positron-emission tomography (3) 3
procarbazine (3) 3
prognosis (3) 3
prospective studies (3) 3
relapse (3) 3
salvage therapy (3) 3
survival (3) 3
survival rate (3) 3
therapy (3) 3
toxicity (3) 3
[ sdv.can ] life sciences [q-bio]/cancer (2) 2
activated phosphoinositide 3-kinase δ syndrome (2) 2
adenopathy (2) 2
alleles (2) 2
analysis (2) 2
and immunodeficiency (2) 2
anemia - etiology (2) 2
anthracyclines (2) 2
antibodies, monoclonal, murine-derived - therapeutic use (2) 2
antibody deficiency (2) 2
antineoplastic agents - therapeutic use (2) 2
antineoplastic combined chemotherapy protocols - adverse effects (2) 2
autografts (2) 2
biomarkers (2) 2
bleomycin (2) 2
blood transfusion (2) 2
bone neoplasms - diagnosis (2) 2
bone neoplasms - mortality (2) 2
bone neoplasms - therapy (2) 2
bone-marrow-transplantation (2) 2
cell survival (2) 2
cells (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2016, Volume 138, Issue 1, pp. 210 - 218.e9
Background Activated phosphoinositide 3-kinase δ syndrome (APDS) 2 (p110δ-activating mutations causing senescent T cells, lymphadenopathy, and immunodeficiency... 
Allergy and Immunology | and immunodeficiency | p110δ-activating mutations causing senescent T cells | hyper-IgM | adenopathy | p110δ | activated phosphoinositide 3-kinase δ syndrome | p85α | antibody deficiency | immunodeficiency | lymphadenopathy | phosphoinositide 3-kinase | Primary immunodeficiency | Class I Phosphatidylinositol 3-Kinases/genetics | RNA Splice Sites | Gene Frequency | Humans | Middle Aged | Immunologic Deficiency Syndromes/diagnosis | Child, Preschool | Genotype | Male | Young Adult | CD8-Positive T-Lymphocytes/immunology | Phenotype | T-Lymphocyte Subsets/immunology | Biopsy | Adolescent | Alleles | Adult | Female | Mutation | Child | Cohort Studies | p110 delta-activating mutations causing senescent T cells | CELLS | HUMAN IMMUNODEFICIENCY | KINASE | p85 alpha | IMMUNOLOGY | p110 delta | ALLERGY | MUTATIONS | activated phosphoinositide 3-kinase delta syndrome | T-Lymphocyte Subsets - immunology | Class I Phosphatidylinositol 3-Kinases - genetics | Immunologic Deficiency Syndromes - etiology | Immunologic Deficiency Syndromes - mortality | CD8-Positive T-Lymphocytes - metabolism | Immunologic Deficiency Syndromes - diagnosis | T-Lymphocyte Subsets - metabolism | CD8-Positive T-Lymphocytes - immunology | Life Sciences | Human health and pathology | Economics and Finance | Psychology | Santé publique et épidémiologie | Humanities and Social Sciences | Psychiatrics and mental health
Journal Article
Journal Article
by Canioni, Danielle and Michot, Jean-Marie and Rabiega, Pascaline and Molina, Thierry J and Charlotte, Frédéric and Lazure, Thierry and Davi, Frédéric and Settegrana, Catherine and Berger, Françoise and Alric, Laurent and Cacoub, Patrice and Terrier, Benjamin and Suarez, Felipe and Sibon, David and Dupuis, Jehan and Feray, Cyrille and Tilly, Hervé and Pol, Stanislas and Deau Fischer, Bénédicte and Roulland, Sandrine and Thieblemont, Catherine and Leblond, Véronique and Carrat, Fabrice and Hermine, Olivier and Besson, Caroline and Archambeaud, Isabelle and Bologna, Serge and Bordessoule, Dominique and Christian, Bernard and Decaudin, Didier and Devidas, Alain and Gabarre, Jean and Genet, Philippe and Grange, Jean-Didier and Gressin, Rémy and Haioun, Corinne and Janvier, Maud and Karlin, Lionel and Karsenti, Jean-Michel and Lepeu, Gérard and Pariente, Alexandre and Sanhes, Laurence and Senecal, Delphine and Stirnemann, Jérome and Arbion, Flavie and Belaouni, Hamid and Bressenot, Aude and Brière, Josette and Brousset, Pierre and Copie-Bergman, Christiane and Costa, Keltoum and Delage-Corre, Manuela and Froment, Nicolas and Martin, Antoine and Meseure, Didier and Michiels, Jean-François and Molina, Thierry and Monier, Jean-François and Picquenot, Jean-Michel and Vincent-Salomon, Anne and Merle-Beral, Hélène and N'GuyenKhac, Florence and Taoufik, Yassine and VentzislavaPetroc-Sanchez, VentzislavaPetroc-Sanchez and Allain, Laurence and Kaabeche, Karim and Petrov-Sanchez, Ventzislava and Rohel, Alexandra and Simony, Mélanie and Barthe, Yoann and Chau, Frédéric and Desgouilles, Anne-Sophie and N'Diaye, Laina and Driss, Henda and Duran, Théo and Félim, Anne and Fotré, Frédéric and Chau, Thi Phi Phung LeFrédéric and Natl ANRS HC13 LymphoC Study and national ANRS HC13 LymphoC study
PLoS ONE, ISSN 1932-6203, 06/2016, Volume 11, Issue 6, p. e0156384
Journal Article
Journal Article
Journal of Nuclear Medicine, ISSN 0161-5505, 10/2019, p. jnumed.119.232827
Anti-PD-1 monoclonal antibodies (anti PD-1 mAbs) such as nivolumab and pembrolizumab are associated with high response rates in patients with relapsed or... 
Life Sciences | Cancer
Journal Article
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 1638 - 1638
Abstract Background: Nivolumab demonstrated remarkable activity in patients with relapse or refractory (R/R) Hodgkin lymphoma (HL). However, long term efficacy... 
Life Sciences | Cancer
Journal Article
Medicine (United States), ISSN 0025-7974, 11/2014, Volume 93, Issue 21, p. e121
Journal Article